´ëÇѽÅÀåÇÐȸ (¿Â¶óÀÎ) KSN 2021 FULLY VIRTUAL MEETING (4ÀÏÂ÷) : 2021-09-05±³À°ÀÏÀÚ : 2021-09-05
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ) KSN 2021 FULLY VIRTUAL MEETING (4ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ
´ã´çÀÚ : ´ëÇѽÅÀåÇÐȸ
¿¬¶ôó : 02-3486-8736
À̸ÞÀÏ :
ksn@ksn.or.kr ±³À°Á¾·ù : ³»°úÀÇ»çÇÐ
Âü¼®¿¹»óÀοø : 2000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡ (ÀÏ¹Ý 4Á¡ / Çʼö 2Á¡)
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 8 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 200,000¿ø
ºñ°í »çÀüµî·Ï : ȸ¿ø:100,000¿ø/ºñȸ¿ø:150,000/Fellow-in-training,Resident,Trainee,Student,Nurse,etc:25,000 ´çÀϵî·Ï : ȸ¿ø:150,000¿ø/ºñȸ¿ø:200,000/Fellow-in-training,Resident,Trainee,Student,Nurse,etc:35,000
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-05 Room1 08:30~09:00 Recent update in the pathogenesis of CKD ¹Ú¼±Èñ(°æºÏÀÇ´ë)
±³À°½Ã°£ 09-05 Room1 09:00~09:30 Diabetes in CKD ¼Û»óÇå(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 09-05 Room1 09:30~10:00 HTN & Heart failure in CKD ±è¾ç±Õ(°æÈñÀÇ´ë)
±³À°½Ã°£ 09-05 Room1 10:00~10:30 Sarcopenia in CKD ¼Û¿µ¸²(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 09-05 Room1 10:30~11:00 Drug induced kidney diseases: how to prevention ±Ç¼ø±æ(ÃæºÏÀÇ´ë)
±³À°½Ã°£ 09-05 Room1 11:00~11:30 Anticoagulant in CKD ¾çÀç¿ø(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 09-05 Room1 11:30~12:00 Use of RAS inhibitors in advanced CKD (aldosterone antagonist Æ÷ÇÔ) ¹ÚÁ¤Å¹(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 09-05 Room1 12:00~12:30 Role of entresto in CKD ±è±âÇ¥(ÀÎÇÏÀÇ´ë)
±³À°½Ã°£ 09-05 Room1 13:30~14:00 KNOW-CKD ¿À±¹È¯(¼¿ïÀÇ´ë)
±³À°½Ã°£ 09-05 Room1 14:00~14:30 KOTRY ¾çÀç¼®(¼¿ïÀÇ´ë)
±³À°½Ã°£ 09-05 Room1 14:30~15:00 ART-KT ÀÌ»óÈ£(°æÈñÀÇ´ë)
±³À°½Ã°£ 09-05 Room1 15:00~15:30 TBD °í°Áö(°í·ÁÀÇ´ë)
±³À°½Ã°£ 09-05 Room1 15:30~16:00 ¼Ò¼È³×Æ®¿öÅ· ¹× ¹Ìµð¾î ÀÌ¿ë¿¡¼ÀÇ ÀÇ·áÀ±¸® ¿ìâÀ±(¿ï»êÀÇ´ë)
±³À°½Ã°£ 09-05 Room1 16:00~16:30 ÀÇ»ç Áý´ÜÇൿ¿¡ ´ëÇÑ À±¸®Àû ¹®Á¦ ¾È´ö¼±(°í·ÁÀÇ´ë)
±³À°½Ã°£ 09-05 Room1 16:30~17:00 Àΰø½ÅÀå½Ç¿¡¼ÀÇ À±¸®Àû ¹®Á¦ ±è»ó¿í(±¤¸í¼ö³»°ú)
±³À°½Ã°£ 09-05 Room1 17:00~17:30 Àΰø½ÅÀå½Ç¿¡¼ ÈçÈ÷ Á¢ÇÏ´Â ¹ýÀû¹®Á¦ ÇöµÎ·û(¹ý¹«¹ýÀÎ ¼¼½Â)